Alexandria Real Estate Equities Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported net income attributable to the company's common stockholders of $18.2 million or $0.47 per basic and diluted share on total revenues of $114.6 million, income from continuing operations of $25.2 million or $0.44 per basic and diluted share compared to net income attributable to the company's common stockholders of $19.3 million or $0.61 per basic and diluted share on total revenues of $112.5 million, income from continuing operations of $26.6 million or $0.58 per basic and diluted share a year ago. Funds from operations (FFO) attributable to the company's common stockholders was $50.6 million or $1.13 per diluted share compared to FFO attributable to the company's common stockholders of $46.27 million or $1.45 per diluted share for the third quarter of 2008. For the nine months, the company reported net income attributable to the company's common stockholders of $83.3 million or $2.26 per basic and diluted share on total revenues of $365.7 million, income from continuing operations of $108.02 million or $2.16 per basic and diluted share compared to net income attributable to the company's common stockholders of $71.5 million or $2.25 per diluted share on total revenues of $327.1 million, income from continuing operations of $74.07 million or $1.68 per basic and diluted share a year ago. FFO attributable to the company's common stockholders was $180.42 million, or $4.49 per diluted share compared to FFO attributable to the company's common stockholders of $130.31 million, or $4.11 per diluted share for nine months ended September 30, 2008. For the year 2009, the company expects that FFO per diluted share attributable to the company's common stockholders of $5.52 and earnings per diluted share attributable to the company's common stockholders of $2.69.

Alexandria Real Estate Equities Inc. expected to Report Fiscal Year 2009 Results on February 10, 2010. This event was calculated by Capital IQ (Created on October 29, 2009).

Alexandria Real Estate Equities, Inc. provided an update highlighting recent accomplishments. Alexandria announced the delivery of a state-of-the-art facility to Pfizer Inc. at the Alexandria Center for Science and Technology at Mission Bay. As announced in August, 2008, Pfizer Inc. entered into a 15-year lease for approximately 102,000 square feet at this dynamic, first-in-class life science cluster. Alexandria's highly skilled development and construction teams worked closely with Pfizer Inc. to develop a robust, flexible and reusable base building with state-of-the-art infrastructure. "We are proud to have worked closely with Pfizer on the design and construction of this state-of-the-art facility. Equally important, we are pleased to note that the building was delivered on time and on budget," said Stephen Richardson, Senior Vice President and Regional Market Director for the San Francisco Bay Area, Alexandria Real Estate Equities, Inc. Also, as part of the ongoing execution of Alexandria's multi-faceted capital plan, Alexandria reported the identification of four properties for sale aggregating approximately 269,000 rentable square feet, including several properties that are under negotiation for sale. These properties will be sold primarily to life science users with anticipated closings over the next several quarters. Total estimated sales prices for these properties, including the three properties that have been sold to date in 2009, aggregate approximately $50 million. The proceeds of these asset sales have and will be used to repay outstanding indebtedness on Alexandria's unsecured revolving line of credit.